Anika Therapeutics, Inc. Financial Ratios — ANIK Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	9.41	11.54	16.83	24.43	15.82	15.01	13.09	7.1	9.85	-8.55	1.48	-5.19	-33.21	-30.79	-7.32
Return on Assets (%)	6.47	8.55	13.8	21.97	14.35	13.68	12.17	6.67	8.92	-6.89	1.16	-4.27	-26.68	-23.82	-5.54
Return on Capital (%)	8.3	10.47	16.19	24.43	15.82	15.01	13.09	7.1	9.47	- -	- -	-4.76	-29.71	- -	- -
Return on Invested Capital (%)	8.41	11.85	16.01	24.4	15.62	14.8	13.01	6.7	9.01	- -	- -	0.6	-0.33	- -	- -
Gross Margin (%)	58.65	59.38	69.68	80.18	77.36	76.76	75.87	70.37	74.92	52.91	56.12	64.33	68.33	63.38	56.56
EBITDA Margin (%)	27.74	37.53	49.4	62.65	55.82	52.56	44.1	26.2	35.11	-0.77	-2.82	15.95	12.47	2.52	-4.72
Operating Margin (%)	21.56	31.19	43.05	58.19	51.76	48.95	40.32	20.6	29.88	-11.09	-12.5	3.22	0.7	-4.25	-9.8
Incremental Operating Margin (%)	69.72	125.93	270.43	95.45	105.69	23.82	-48.58	304.9	138.03	- -	- -	-65.21	-40.57	- -	- -
Pretax Margin (%)	21.28	27.37	43.26	58.25	51.89	49.21	40.74	21.99	31.52	-21.94	1.64	3.8	2.61	-2.31	-8.25
Profit Margin (%)	13.07	16.48	27.4	36.29	33.07	31.48	28.05	17.74	23.73	-18.38	2.8	-13.05	-68.44	-47.02	-9.64
Net Income to Common Margin (%)	13.07	16.48	27.4	36.29	33.07	31.48	28.05	17.74	23.73	-18.38	2.8	-13.05	-68.44	-47.02	-9.64
Effective Tax Rate (%)	38.58	39.79	36.65	37.7	36.26	36.02	31.14	19.33	24.72	- -	- -	49.12	208.97	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	9.41	11.54	16.83	24.43	15.82	15.01	13.09	7.1	9.85	-8.55	1.48	-5.19	-33.21	-30.79	-7.32

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	11	10	- -	- -	- -	- -	- -	- -	23	22	21	31	28	26	26
ST Debt	2	2	- -	- -	- -	- -	- -	- -	1	2	2	2	2	2	2
LT Debt	10	8	- -	- -	- -	- -	- -	- -	21	21	19	29	26	24	24
Total Debt/EBITDA	0.62	0.36	- -	- -	- -	- -	- -	- -	0.56	-22.37	-5.03	1.7	1.84	8.59	-4.93
Net Debt/EBITDA	-1.37	-1.29	-1.71	-1.51	-2.13	-1.92	-2.66	-3.22	-3.91	95.44	22.67	-4.75	-4.56	-18.42	10.8
Total Debt/EBIT	0.8	0.43	- -	- -	- -	- -	- -	- -	0.66	-1.55	-1.13	8.42	32.87	-5.08	-2.38
Net Debt/EBIT	-1.76	-1.55	-1.96	-1.63	-2.3	-2.06	-2.91	-4.09	-4.6	6.62	5.11	-23.52	-81.45	10.91	5.2
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	71.33	76.67	86.92	92.37	89.44	92.73	93.23	94.49	87.2	74.51	82.61	81.79	78.43	75.95	75.4
Long-Term Debt/Equity (%)	10.13	7.34	- -	- -	- -	- -	- -	- -	7.41	7.66	6.7	10.09	12.21	15.59	16.87
Long-Term Debt/Capital (%)	9.06	6.75	- -	- -	- -	- -	- -	- -	6.87	7.08	6.25	9.11	10.8	13.35	14.26
Long-Term Debt/Total Assets (%)	7.23	5.63	- -	- -	- -	- -	- -	- -	6.46	5.71	5.54	8.25	9.58	11.84	12.72
Total Debt/Equity (%)	11.82	8.81	- -	- -	- -	- -	- -	- -	7.81	8.25	7.3	10.82	13.07	16.84	18.3
Total Debt/Capital (%)	10.57	8.1	- -	- -	- -	- -	- -	- -	7.24	7.62	6.8	9.76	11.56	14.41	15.47
Total Debt/Total Assets (%)	8.43	6.76	- -	- -	- -	- -	- -	- -	6.81	6.14	6.03	8.85	10.25	12.79	13.8
Net Debt to Equity	-25.94	-31.64	-46.69	-56.24	-52.51	-46.8	-50.57	-33.78	-54.6	-35.18	-32.88	-30.23	-32.38	-36.13	-40.07
Net Debt/Capital (%)	-35.02	-46.29	-87.6	-128.5	-110.55	-87.98	-102.32	-51.01	-102.63	-48.14	-44.18	-37.51	-40.14	-44.76	-51.22
EBITDA	18	27	37	66	52	54	50	28	40	-1	-4	18	15	3	-5
EBITDA-CapEx	17	25	37	65	43	40	41	23	37	-3	-9	11	10	-5	-12
Operating Income (Loss)	14	22	32	61	48	51	46	22	34	-14	-18	4	1	-5	-11

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.46	3.05	6.82	17.9	8.01	14.18	12.03	14.09	11.36	2.67	3.17	3.09	2.21	2.39	2.62
Current Ratio	4.41	5.35	10.19	23.08	10.21	19.37	15.78	17.98	14.39	4.81	5.66	6.07	5.26	4.88	4.72
Quick Ratio	3.65	4.53	8.84	20.77	9.27	17.32	13.85	15.93	12.78	3.32	4.17	4.33	3.06	3.4	3.71
CFO/Avg Current Liab	0.6	0.73	2.12	5.24	3.43	1.88	3.73	2.87	2.68	0.49	0.25	0.15	-0.06	0.2	0.49
Common Equity/Total Assets	71.33	76.67	86.92	92.37	89.44	92.73	93.23	94.49	87.2	74.51	82.61	81.79	78.43	75.95	75.4
Long-Term Debt/Equity (%)	10.13	7.34	- -	- -	- -	- -	- -	- -	7.41	7.66	6.7	10.09	12.21	15.59	16.87
Long-Term Debt/Capital (%)	9.06	6.75	- -	- -	- -	- -	- -	- -	6.87	7.08	6.25	9.11	10.8	13.35	14.26
Long-Term Debt/Total Assets (%)	7.23	5.63	- -	- -	- -	- -	- -	- -	6.46	5.71	5.54	8.25	9.58	11.84	12.72
Total Debt/Equity (%)	11.82	8.81	- -	- -	- -	- -	- -	- -	7.81	8.25	7.3	10.82	13.07	16.84	18.3
Total Debt/Capital (%)	10.57	8.1	- -	- -	- -	- -	- -	- -	7.24	7.62	6.8	9.76	11.56	14.41	15.47
Total Debt/Total Assets (%)	8.43	6.76	- -	- -	- -	- -	- -	- -	6.81	6.14	6.03	8.85	10.25	12.79	13.8
CFO/Total Liabilities	26.71	31.83	123.31	271.77	160.29	139.92	213.38	227.02	87.42	14.02	13.89	6.94	-3.06	11.08	23.9
CFO/CapEx	7.26	7.01	57.06	25.74	4.33	1.74	4.54	7.5	13.09	8.03	1.63	0.59	-0.33	0.65	1.64
Altman's Z-Score	4.27	5.02	18.99	28.3	16.75	27.73	27.78	21.35	13.16	6.28	7.35	6.3	5.19	4.54	3.15

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.03	3.68	3.74	5.88	4.79	4.2	4.41	4.73	5.23	5.53	5.48	3.53	3.96	4.8	4.77
Days Sales Outstanding	90.51	99.16	97.71	62.03	76.15	86.94	82.74	77.11	69.83	66	66.61	103.37	92.14	76.03	76.49
Inventory Turnover	3.3	3.72	2.36	1.79	1.54	1.55	1.44	1.44	1.33	1.8	1.58	1.07	1.19	1.82	2.3
Days Inventory Outstanding	110.74	98.12	154.56	204.07	237.04	234.86	253.56	252.83	274.86	202.62	231.38	340.56	306.2	200.49	158.61
Accounts Payable Turnover	3.59	9.02	9.92	11.18	4.96	4.73	7.38	6.18	8.44	13.37	6.58	5.31	3	7.33	7.55
Accounts Payable Turnover Days	101.6	40.44	36.79	32.63	73.54	77.19	49.43	59.09	43.24	27.31	55.49	68.73	121.56	49.79	48.37
Cash Conversion Cycle	99.65	156.83	215.49	233.46	239.65	244.61	286.87	270.85	301.45	241.31	242.5	375.19	276.79	226.73	186.73
Inventory to Cash Days	-20.23	1.03	-56.85	-142.04	-160.89	-147.92	-170.81	-175.72	-205.03	-136.62	-164.76	-237.19	-214.06	-124.46	-82.12
Inventories	7	8	11	12	15	16	22	21	22	46	36	40	24	24	19
Raw Materials	4	6	6	6	6	6	11	14	12	15	17	21	- -	- -	- -
Work In Process	2	1	2	3	6	6	6	5	8	13	11	11	- -	- -	- -
Finished Goods	2	1	3	3	4	5	5	7	9	33	27	25	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	-4	-7	-15	-19	-17	24	24	19

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	134	138	545	605	574	716	792	478	742	649	517	433	332	237	133
- Cash & Cash Equivalents	36	44	63	100	111	104	133	89	157	96	94	86	69	56	57
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	11	10	- -	- -	- -	- -	- -	- -	23	22	21	31	28	26	26
Enterprise Value	109	103	482	498	435	591	635	319	579	573	444	377	291	208	102
Total Capital	106	119	136	178	211	223	263	264	311	295	308	316	240	180	170
Total Debt/Capital (%)	10.57	8.1	- -	- -	- -	- -	- -	- -	7.24	7.62	6.8	9.76	11.56	14.41	15.47
Total Debt / EV	0.1	0.09	- -	- -	- -	- -	- -	- -	0.04	0.04	0.05	0.08	0.1	0.12	0.26
EV/Sales	1.68	1.45	6.42	4.72	4.68	5.72	5.59	3.02	5.06	4.39	3	3.32	2.41	1.73	0.91
EV/EBITDA	6.07	3.86	12.99	7.53	8.39	10.88	12.69	11.52	14.4	- -	- -	20.79	19.33	68.74	- -
EV/EBIT	7.8	4.64	14.91	8.11	9.04	11.69	13.88	14.65	16.92	- -	- -	102.85	345.02	- -	- -
EV/Cash Flow to Firm	10.71	9.8	19.15	12.46	10.91	24.19	15.55	9.12	15.66	43.83	52.87	85.61	- -	38.42	9.14
EV/Free Cash Flow to Firm	9.42	8.58	18.82	11.99	8.86	15.38	12.74	8.05	14.55	38.98	32.79	31.73	80.02	15.11	5.68
Diluted Market Cap	135	143	566	622	585	740	812	494	745	644	524	431	332	242	138
Diluted Enterprise Value	110	108	502	522	474	636	679	405	610	570	451	376	291	213	107
EV per Share	8	7.45	33.73	33.54	28.95	40.43	43.2	22.42	40.5	39.97	30.75	25.81	19.86	14.4	7.36
TTM Sales	65	71	75	106	93	103	113	106	115	130	148	114	121	120	113
TTM EBITDA	18	27	37	66	52	54	50	28	40	-1	-4	18	15	3	-5
TTM Operating Income	14	22	32	61	48	51	46	22	34	-14	-18	4	1	-5	-11
TTM Cash Flow to Firm	10	11	25	40	40	24	41	35	37	13	8	4	-2	5	11
TTM Free Cash Flow to Firm	12	12	26	42	49	38	50	40	40	15	14	12	4	14	18

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	11.64	11.83	22.09	14.98	11.9	19.24	16.31	12.48	18.71	43.81	38.72	36.23	91.26	17.64	7.65
EV/EBIT	7.8	4.64	14.91	8.11	9.04	11.69	13.88	14.65	16.92	- -	- -	102.85	345.02	- -	- -
Enterprise Value	109	103	482	498	435	591	635	319	579	573	444	377	291	208	102
Low Price	5.24	9	10	28.79	30.93	35.07	41.64	28.54	29.01	22.01	32.3	19.95	16.54	15.83	7.87
EV/Sales	1.68	1.45	6.42	4.72	4.68	5.72	5.59	3.02	5.06	4.39	3	3.32	2.41	1.73	0.91
EV/EBITDA	6.07	3.86	12.99	7.53	8.39	10.88	12.69	11.52	14.4	- -	- -	20.79	19.33	68.74	- -
Price/Earnings	15.12	11.21	26.13	15.61	18.53	22.09	24.7	25.93	26.93	- -	124.82	- -	- -	- -	- -
Price/Earnings Average	11.62	14.33	13.7	15.71	18.1	20.7	23.07	33.33	23.47	-21.86	140.93	-25.53	-4.34	-6.25	-15.84
Price/Earnings High	18.01	19.96	26.48	20.11	22.02	24.79	27.62	53.85	39.32	-32.68	168.5	-36.11	-5.73	-7.6	-24.21
Price/Earnings Low	8.09	10.15	6.85	11.03	15.02	15.82	19.08	22.02	15.06	-13.05	112.52	-19.55	-2.93	-4.13	-10.37
Price/Book Value	1.41	1.27	4.02	3.4	2.72	3.21	3.01	1.81	2.57	2.38	1.8	1.52	1.57	1.54	0.93
Price/Book Value Average	1.08	1.62	2.11	3.42	2.66	3.01	2.81	2.33	2.24	1.94	2.04	1.33	1.69	2.24	1.16
Price/Book Value High	1.68	2.25	4.07	4.38	3.23	3.61	3.36	3.76	3.76	2.9	2.43	1.89	2.23	2.73	1.78
Price/Book Value Low	0.75	1.15	1.05	2.4	2.21	2.3	2.32	1.54	1.44	1.16	1.62	1.02	1.14	1.48	0.76
Price/Tangible Book Value	2.13	1.73	5.09	3.91	2.99	3.49	3.24	1.94	2.72	3.75	2.63	2.13	1.64	1.64	1
Price/Tangible Book Value Average	1.64	2.22	2.67	3.93	2.92	3.27	3.02	2.49	2.37	3.06	2.97	1.87	1.77	2.39	1.25
Price/Tangible Book Value High	2.54	3.09	5.16	5.03	3.56	3.92	3.62	4.02	3.97	4.57	3.55	2.65	2.34	2.91	1.91
Price/Tangible Book Value Low	1.14	1.57	1.33	2.76	2.43	2.5	2.5	1.64	1.52	1.82	2.37	1.43	1.2	1.58	0.82
Price/Sales	1.98	1.85	7.16	5.66	6.13	6.95	6.93	4.6	6.39	4.93	3.49	3.79	2.75	2.02	1.22
Price/Sales Average	1.52	2.36	3.75	5.7	5.99	6.52	6.47	5.91	5.57	4.02	3.94	3.33	2.97	2.94	1.53
Price/Sales High	2.35	3.29	7.26	7.3	7.28	7.81	7.75	9.55	9.33	6.01	4.71	4.71	3.92	3.58	2.33
Price/Sales Low	1.06	1.67	1.88	4	4.97	4.98	5.35	3.9	3.57	2.4	3.15	2.55	2.01	1.94	1
Price/Cash Flow	12.58	12.5	21.36	14.96	14.28	29.4	19.25	13.9	19.79	49.27	61.45	97.76	-185.74	44.85	12.32
Price/Cash Flow Average	9.67	15.98	11.2	15.06	13.95	27.56	17.99	17.87	17.25	40.12	69.38	86.03	-200.48	65.2	15.4
Price/Cash Flow High	14.99	22.25	21.65	19.27	16.97	33.01	21.53	28.87	28.89	59.98	82.96	121.68	-265	79.35	23.54
Price/Cash Flow Low	6.73	11.31	5.6	10.57	11.57	21.06	14.87	11.8	11.07	23.96	55.4	65.89	-135.58	43.13	10.09
Price/Free Cash Flow Average	8.94	15.12	11.58	15.08	11.62	18.03	15.24	16.04	16.31	35.67	43.72	31.89	98.51	25.65	9.57
Price/Free Cash Flow High	13.86	21.06	22.4	19.3	14.14	21.6	18.24	25.91	27.32	53.33	52.28	45.1	130.21	31.21	14.62
Price/Free Cash Flow Low	6.22	10.71	5.79	10.59	9.64	13.78	12.6	10.59	10.47	21.3	34.91	24.42	66.61	16.96	6.26
EV/Sales Average	1.2	1.99	2.96	4.82	4.84	5.48	5.35	4.97	4.47	3.49	3.46	2.86	2.63	2.63	1.2
EV/Sales High	2.08	2.96	6.52	6.43	6.14	6.77	6.63	8.55	8.27	5.49	4.23	4.25	3.58	3.25	1.98
EV/Sales Low	0.72	1.27	1.06	3.1	3.81	3.95	4.22	3	2.44	1.86	2.66	2.08	1.67	1.66	0.69
EV/EBITDA Average	4.34	5.29	6	7.69	8.66	10.43	12.12	18.98	12.72	-452.92	-122.7	17.93	21.08	104.4	-25.5
EV/EBITDA High	7.48	7.88	13.19	10.27	11	12.87	15.04	32.64	23.57	-713.32	-150.15	26.62	28.75	129.17	-42.07
EV/EBITDA Low	2.61	3.37	2.14	4.95	6.83	7.52	9.56	11.44	6.96	-241.06	-94.41	13.02	13.38	65.73	-14.67
EV/EBIT Average	5.59	6.37	6.89	8.28	9.34	11.2	13.26	24.14	14.94	-31.43	-27.64	88.7	376.26	-61.81	-12.28
EV/EBIT High	9.63	9.48	15.14	11.06	11.87	13.82	16.45	41.52	27.69	-49.5	-33.82	131.72	512.99	-76.47	-20.26
EV/EBIT Low	3.35	4.06	2.46	5.33	7.36	8.08	10.46	14.55	8.18	-16.73	-21.27	64.4	238.72	-38.92	-7.06
Last Price	9.8	9.94	38.16	40.74	38.16	48.96	53.91	33.61	51.85	45.26	35.83	29.6	22.66	16.46	9.61
High Price	11.67	17.7	38.68	52.49	45.35	54.96	60.29	69.81	75.72	55.1	48.37	36.84	32.33	29.12	18.37
Enterprise Value Average	78	142	223	509	450	567	606	525	512	455	511	326	318	315	136
Enterprise Value High	134	211	489	679	571	700	752	903	948	716	625	483	433	390	224
Enterprise Value Low	47	90	80	327	354	409	478	317	280	242	393	236	201	199	78

Shares Outstanding	14	14	14	15	15	15	15	14	14	14	14	15	15	14	14
Diluted Weighted Avg Shares	14	14	15	15	15	15	15	15	14	14	15	15	15	15	14
Basic Weighted Avg Shares	13	13	14	15	15	15	15	14	14	14	14	15	15	15	14
Revenue per Share	4.96	5.38	5.33	7.19	6.23	7.04	7.78	7.31	8.12	9.17	10.26	7.82	8.24	8.14	7.87
EBITDA per Share	1.38	2.02	2.63	4.51	3.48	3.7	3.43	1.92	2.85	-0.07	-0.29	1.25	1.03	0.21	-0.37
Operating Income per Share	1.07	1.68	2.29	4.19	3.22	3.45	3.14	1.51	2.43	-1.02	-1.28	0.25	0.06	-0.35	-0.77
Basic EPS, GAAP	0.65	0.89	1.46	2.61	2.06	2.22	2.18	1.3	1.93	-1.69	0.29	-1.02	-5.64	-3.83	-0.76
Basic EPS from Cont Ops	0.65	0.89	1.46	2.61	2.06	2.22	2.18	1.3	1.93	-1.69	0.29	0.15	-0.23	-0.6	-0.7
Diluted EPS, GAAP	0.62	0.82	1.39	2.51	2.01	2.15	2.11	1.27	1.89	-1.69	0.28	-1.02	-5.64	-3.83	-0.76
Diluted EPS from Cont Ops	0.62	0.82	1.39	2.51	2.01	2.15	2.11	1.27	1.89	-1.69	0.28	0.15	-0.23	-0.6	-0.7
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.78	0.8	1.79	2.72	2.67	1.67	2.8	2.42	2.62	0.92	0.58	0.3	-0.12	0.37	0.78
Free Cash Flow per Basic Share	0.67	0.68	1.76	2.62	2.05	0.71	2.18	2.1	2.42	0.8	0.23	-0.21	-0.49	-0.2	0.3
Cash & Equivalents per Share	2.62	3.18	4.43	7.2	9.21	8.53	10.71	11.19	12.93	6.86	6.54	5.9	4.69	3.86	4.14
Book Value per Share	6.95	7.86	9.49	11.99	14.02	15.23	17.94	18.55	20.16	19.01	19.88	19.53	14.48	10.68	10.33
Tangible Book Value per Share	4.6	5.74	7.5	10.43	12.75	14.04	16.66	17.35	19.09	12.06	13.64	13.92	13.79	10.01	9.63

Anika Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)